SecBot SecBot
8-K ·Filed Apr 29, 2026

PMHS

Polomar Health Services, Inc.
BEARISH
Impact 6/10
Horizonweeks Processed6mo ago SEC0001493152-26-019659
8-K material event: Items 1.02
Actionable Insight ▼ Bearish

Watch for further disclosures on dispute resolution or litigation. The stock may face downward pressure due to revenue loss and legal costs. No immediate catalyst; monitor for updates on ForHumanity's actions.

DirectionBearish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
PMHS ▼ -33.33% at T+60d
SHORT call ✓ call won +33.33% · α vs SPY +36.44% · entry $0.1200 → $0.0800
Entry = T+0 close
Apr 29, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.22%
$0.1200
settled 6mo ago
T+5d
+300.00%
call -300.00% · α -298.27%
$0.4800
settled 6mo ago
T+20d
-40.00%
call +40.00% · α +45.23%
$0.0720
settled 5mo ago
T+60d
-33.33%
call +33.33% · α +36.44%
$0.0800
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Polomar Health Services received a notice from ForHumanity, Inc. to terminate and rescind the Product Fulfillment and Distribution Agreement, which allowed ForHumanity exclusive marketing rights. The notice alleges fraudulent representations; Polomar disputes the claims and believes ForHumanity is in default. The termination jeopardizes a guaranteed payment of $750,000 (of which $500,000 has been paid) and potential future revenue of up to $5 million, creating significant uncertainty.

Key Facts

  • Received termination notice from ForHumanity on April 23, 2026
  • ForHumanity claims fraudulent inducement; Polomar disputes
  • $750,000 guaranteed payment, of which $500,000 has been paid
  • Agreement included exclusivity and revenue commitments up to $5 million

Financial Impact

At least $250,000 remaining guaranteed payment at risk; potential loss of up to $5 million in gross revenue from ForHumanity for 2026

revenuefuture revenue prospects

Risk Factors

  • Litigation costs and management distraction
  • Loss of exclusive distribution channel
  • Reputational damage from fraud allegations

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-019659
Document: 0001493152-26-019659-index-headers.html0001493152-26-019659
Document: 0001493152-26-019659-index.html0001493152-26-019659
Document: 0001493152-26-019659.txt0001493152-26-019659
4 reports for PMHS
Performance horizon
Filters
Rows
Reports for PMHS — sortable, filterable
TypeNow
Oct 19, 2026
7d ago
8-K
NEUTRAL ★ 3/10
$0.1236awaiting T+60—$0.1500 (+21.36%)
Sep 24, 2026
4w ago
EFFECT
NEUTRAL ★ 3/10
$0.1500awaiting T+60—$0.1500 (+0.00%)
May 15, 2026
23w ago
8-K
MIXED ★ 6/10
$0.3000 $0.1500▼ −50.00%▼ −54.85%$0.1500 (−50.00%)
Apr 29, 2026
25w ago
8-K
BEARISH ★ 6/10
$0.1200 $0.0800▲ +33.33%▲ +36.44%$0.1500 (−25.00%)
Showing 4 of 4

US Market Status

Market Open — Closes in 3h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 29, 2026